RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Opiant Pharmaceuticals EBIT 2024

Opiant Pharmaceuticals EBIT

-21.32 M USD

Opiant Pharmaceuticals Dividend yield

Ticker

OPNT

ISIN

US6837501039

WKN

A2AFQ6

In 2024, Opiant Pharmaceuticals's EBIT was -21.32 M USD, a -32.36% increase from the -31.52 M USD EBIT recorded in the previous year.

The Opiant Pharmaceuticals EBIT history

YEAREBIT (undefined USD)
2026e18.76
2025e19.49
2024e-21.32
2023e-31.52
2022e-42.43
20215.16
2020-2.24
201910.91
2018-21.19
20171.54
20167.09
2015-7.74
2014-6.9
2013-11.3
2012-8.81
2011-12.34
2010-9.44
2009-2.02
2008-0.01
2007-0.02
2006-0.03
2005-0.03

Opiant Pharmaceuticals Aktienanalyse

What does Opiant Pharmaceuticals do?

Opiant Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of medications for the treatment of addiction disorders and acute medical needs. The company was founded in 2006 and is headquartered in Santa Monica, California. Since its inception, Opiant Pharmaceuticals Inc. has developed innovative drugs that can help mitigate the effects of addiction disorders and meet the demand for emergency medications. The company follows a clear business model based on the implementation of clinical trials and the commercialization of the resulting medications. One of Opiant Pharmaceuticals Inc.'s core areas is the development of medications that can be used in the context of opioid overdoses. One of the best-known products is Narcan Nasal Spray, an emergency medication that can be used in cases of opioid overdose. The product is fast, easy, and safe to use and has proven to be highly effective in practice. In addition to the development of medications for the treatment of opioid overdoses, Opiant Pharmaceuticals Inc. has also developed medications for the treatment of alcohol dependence. One of the best-known medications is Nalmefene, sold as Selincro in Europe and Canada. The medication is used in combination with behavioral counseling and has proven to be an effective treatment option for patients with alcohol dependence. Another division of Opiant Pharmaceuticals Inc. is the development of medications for acute medical needs. This includes medications such as Fentanyl Nasal Spray, which can be used for the treatment of acute pain. Another medication is the opioid analgesic Oxycodone combined with Naltrexone, which is used for the treatment of moderate to severe pain. In addition, Opiant Pharmaceuticals Inc. also has a wide range of products in the pipeline that are in various stages of development and clinical trials. These include medications for the treatment of methamphetamine and cocaine dependence, as well as for postoperative nausea and vomiting. The company actively invests in research and development and is constantly striving to develop innovative and effective medications that can help minimize the effects of addiction disorders and meet medical needs. Overall, Opiant Pharmaceuticals Inc. has established itself as a leading provider of medications for the treatment of addiction disorders. The company has an impressive track record in drug development and aims to offer effective treatment options to patients around the world. With a strong pipeline of products and a dedicated leadership team, Opiant Pharmaceuticals Inc. is well-positioned to continue growing in the coming years and establish itself as a leading provider of medications for the treatment of addiction disorders. Opiant Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Opiant Pharmaceuticals's EBIT

Opiant Pharmaceuticals's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Opiant Pharmaceuticals's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Opiant Pharmaceuticals's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Opiant Pharmaceuticals’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Opiant Pharmaceuticals Stock

How much did Opiant Pharmaceuticals achieve in EBIT for the current year?

In the current year, Opiant Pharmaceuticals has achieved an EBIT of -21.32 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Opiant Pharmaceuticals.

How has the EBIT of Opiant Pharmaceuticals developed in recent years?

The EBIT of Opiant Pharmaceuticals has increased by -32.362% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Opiant Pharmaceuticals?

The EBIT of Opiant Pharmaceuticals is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Opiant Pharmaceuticals pay?

Over the past 12 months, Opiant Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Opiant Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Opiant Pharmaceuticals?

The current dividend yield of Opiant Pharmaceuticals is .

When does Opiant Pharmaceuticals pay dividends?

Opiant Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Opiant Pharmaceuticals?

Opiant Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Opiant Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Opiant Pharmaceuticals located?

Opiant Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Opiant Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Opiant Pharmaceuticals from 4/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/28/2024.

When did Opiant Pharmaceuticals pay the last dividend?

The last dividend was paid out on 4/28/2024.

What was the dividend of Opiant Pharmaceuticals in the year 2023?

In the year 2023, Opiant Pharmaceuticals distributed 0 USD as dividends.

In which currency does Opiant Pharmaceuticals pay out the dividend?

The dividends of Opiant Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Opiant Pharmaceuticals

Our stock analysis for Opiant Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Opiant Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.